{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:10:28Z","timestamp":1766981428152,"version":"3.48.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,28]]},"DOI":"10.7759\/cureus.100284","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:09:31Z","timestamp":1766981371000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Safety and Efficacy of Left Atrial Appendage Occlusion Technologies for Prevention of Stroke and Bleeding in Atrial Fibrillation: A Comprehensive Meta-Analysis of Watchman Versus Oral Anticoagulation and Alternative Device Platforms"],"prefix":"10.7759","author":[{"given":"Efe","family":"Opone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafees","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidra","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2016:1:1","article-title":"Identification of patients at risk of stroke from atrial fibrillation","volume":"10","author":"Fohtung RB","year":"2016","unstructured":"Fohtung RB, Rich MW. Identification of patients at risk of stroke from atrial fibrillation. US Cardiology Review. 2016, 10:60-4. 10.15420\/usc.2016:1:1","journal-title":"US Cardiology Review"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14403-2","article-title":"Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: results from a Global Burden of Disease Study, 2019","volume":"22","author":"Li H","year":"2022","unstructured":"Li H, Song X, Liang Y, et al.. Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: results from a Global Burden of Disease Study, 2019. BMC Public Health. 2022, 22:2015. 10.1186\/s12889-022-14403-2","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101330","article-title":"Prevalence, management, and comorbidities of adults with atrial fibrillation in the United States, 2019 to 2023","volume":"3","author":"Oltman CG","year":"2024","unstructured":"Oltman CG, Kim TP, Lee JW, Lupu JD, Zhu R, Moussa ID. Prevalence, management, and comorbidities of adults with atrial fibrillation in the United States, 2019 to 2023. JACC Adv. 2024, 3:101330. 10.1016\/j.jacadv.2024.101330","journal-title":"JACC Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/hrs guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"83","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/hrs guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2024, 83:109-279. 10.1016\/j.jacc.2023.08.017","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23690","article-title":"Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: systematic review and meta-analysis","volume":"44","author":"Jiang H","year":"2021","unstructured":"Jiang H, Jiang Y, Ma H, Zeng H, Lv J. Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: systematic review and meta-analysis. Clin Cardiol. 2021, 44:1208-15. 10.1002\/clc.23690","journal-title":"Clin Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020904","article-title":"Direct oral anticoagulant adherence of patients with atrial fibrillation transitioned from warfarin","volume":"10","author":"Pundi KN","year":"2021","unstructured":"Pundi KN, Perino AC, Fan J, et al.. Direct oral anticoagulant adherence of patients with atrial fibrillation transitioned from warfarin. J Am Heart Assoc. 2021, 10:e020904. 10.1161\/JAHA.121.020904","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw159","article-title":"The left atrial appendage: from embryology to prevention of thromboembolism","volume":"38","author":"Patti G","year":"2017","unstructured":"Patti G, Pengo V, Marcucci R, et al.. The left atrial appendage: from embryology to prevention of thromboembolism. Eur Heart J. 2017, 38:877-87. 10.1093\/eurheartj\/ehw159","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy VY","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, et al.. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014, 312:1988-98. 10.1001\/jama.2014.15192","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes DR Jr","year":"2014","unstructured":"Holmes DR Jr, Kar S, Price MJ, et al.. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014, 64:1-12. 10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002246","article-title":"Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings","volume":"10","author":"Sakriss C","year":"2023","unstructured":"Sakriss C, Roehl P, Schwenzky A, Hoyme M, Ebelt H. Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings. Open Heart. 2023, 10:e002246. 10.1136\/openhrt-2022-002246","journal-title":"Open Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.089","article-title":"Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy","volume":"62","author":"Urena M","year":"2013","unstructured":"Urena M, Rod\u00e9s-Cabau J, Freixa X, et al.. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013, 62:96-102. 10.1016\/j.jacc.2013.02.089","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik P","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P, et al.. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022, 79:1-14. 10.1016\/j.jacc.2021.10.023","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3791\/3671","article-title":"The WATCHMAN left atrial appendage closure device for atrial fibrillation","author":"M\u00f6bius-Winkler S","year":"2012","unstructured":"M\u00f6bius-Winkler S, Sandri M, Mangner N, Lurz P, D\u00e4hnert I, Schuler G. The WATCHMAN left atrial appendage closure device for atrial fibrillation. J Vis Exp. 2012, 3671. 10.3791\/3671","journal-title":"J Vis Exp"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5114\/aic.2017.66188","article-title":"The Watchman FLX - a new device for left atrial appendage occlusion - design, potential benefits and first clinical experience","volume":"13","author":"Grygier M","year":"2017","unstructured":"Grygier M, Olasi\u0144ska-Wi\u015bniewska A, Araszkiewicz A, Trojnarska O, Babicz-Sadowska A, Lesiak M. The Watchman FLX - a new device for left atrial appendage occlusion - design, potential benefits and first clinical experience. Postepy Kardiol Interwencyjnej. 2017, 13:62-6. 10.5114\/aic.2017.66188","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV11I13A292","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach","volume":"11","author":"Tzikas A","year":"2016","unstructured":"Tzikas A, Gafoor S, Meerkin D, et al.. Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. EuroIntervention. 2016, 11:1512-21. 10.4244\/EIJV11I13A292","journal-title":"EuroIntervention"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2013.04.003","article-title":"A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation","volume":"14","author":"Lam YY","year":"2013","unstructured":"Lam YY. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. Cardiovasc Revasc Med. 2013, 14:134-6. 10.1016\/j.carrev.2013.04.003","journal-title":"Cardiovasc Revasc Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref20","article-title":"Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness","author":"Gierisch JM","year":"2014","unstructured":"Gierisch JM, Beadles C, Shapiro A, et al.. Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness. Department of Veterans Affairs, Washington, D.C.; 2014."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.04.029","article-title":"Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: concomitant and sequential cohorts of the OPTION randomized controlled trial","volume":"22","author":"Saliba W","year":"2025","unstructured":"Saliba W, Nair D, Swarup V, et al.. Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: concomitant and sequential cohorts of the OPTION randomized controlled trial. Heart Rhythm. 2025, 22:2585-94. 10.1016\/j.hrthm.2025.04.029","journal-title":"Heart Rhythm"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"AMPLATZER Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy D","year":"2021","unstructured":"Lakkireddy D, Thaler D, Ellis CR, et al.. AMPLATZER Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation. 2021, 144:1543-52. 10.1161\/CIRCULATIONAHA.121.057063","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067312","article-title":"Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation","volume":"149","author":"Kapadia SR","year":"2024","unstructured":"Kapadia SR, Krishnaswamy A, Whisenant B, et al.. Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation. Circulation. 2024, 149:734-43. 10.1161\/CIRCULATIONAHA.123.067312","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea R","year":"2022","unstructured":"Galea R, De Marco F, Meneveau N, et al.. Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial. Circulation. 2022, 145:724-38. 10.1161\/CIRCULATIONAHA.121.057859","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2024.12.008","article-title":"A membrane modification technique for left atrial appendage occlusion: a multicenter randomized controlled trial","volume":"5","author":"Fan Y","year":"2025","unstructured":"Fan Y, Ma D, Wang C, et al.. A membrane modification technique for left atrial appendage occlusion: a multicenter randomized controlled trial. JACC Asia. 2025, 5:374-87. 10.1016\/j.jacasi.2024.12.008","journal-title":"JACC Asia"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25230","article-title":"Significance of the learning curve in left atrial appendage occlusion with two different devices","volume":"83","author":"Cruz-Gonzalez I","year":"2014","unstructured":"Cruz-Gonzalez I, Perez-Rivera A, Lopez-Jimenez R, et al.. Significance of the learning curve in left atrial appendage occlusion with two different devices. Catheter Cardiovasc Interv. 2014, 83:642-6. 10.1002\/ccd.25230","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0899-9","article-title":"Real-world experience comparing two common left atrial appendage closure devices","volume":"18","author":"Fastner C","year":"2018","unstructured":"Fastner C, Hoffmann L, Aboukoura M, et al.. Real-world experience comparing two common left atrial appendage closure devices. BMC Cardiovasc Disord. 2018, 18:171. 10.1186\/s12872-018-0899-9","journal-title":"BMC Cardiovasc Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2018.10.010","article-title":"Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation","volume":"73","author":"Chen S","year":"2019","unstructured":"Chen S, Chun KR, Bordignon S, et al.. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation. J Cardiol. 2019, 73:299-306. 10.1016\/j.jjcc.2018.10.010","journal-title":"J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4244\/AIJ-D-18-00013","article-title":"Comparison of three left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation: a single-centre seven-year experience with WATCHMAN, AMPLATZER Cardiac Plug\/Amulet, LAmbre: comparison of three LAAO devices for stroke prevention","volume":"5","author":"Cheung GS","year":"2019","unstructured":"Cheung GS, So KC, Chan CK, Chan AK, Lee AP, Lam YY, Yan BP. Comparison of three left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation: a single-centre seven-year experience with WATCHMAN, AMPLATZER Cardiac Plug\/Amulet, LAmbre: comparison of three LAAO devices for stroke prevention. AsiaIntervention. 2019, 5:57-63. 10.4244\/AIJ-D-18-00013","journal-title":"AsiaIntervention"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02708-4","article-title":"Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)","volume":"22","author":"Kretzler L","year":"2022","unstructured":"Kretzler L, Mues C, Wunderlich C, et al.. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure). BMC Cardiovasc Disord. 2022, 22:271. 10.1186\/s12872-022-02708-4","journal-title":"BMC Cardiovasc Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-021-01002-1","article-title":"One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices","volume":"64","author":"Mansour MJ","year":"2022","unstructured":"Mansour MJ, Harnay E, Al Ayouby A, et al.. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices. J Interv Card Electrophysiol. 2022, 64:27-34. 10.1007\/s10840-021-01002-1","journal-title":"J Interv Card Electrophysiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa001","article-title":"Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC)","volume":"22","author":"Kleinecke C","year":"2020","unstructured":"Kleinecke C, Yu J, Neef P, et al.. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC). Europace. 2020, 22:916-23. 10.1093\/europace\/euaa001","journal-title":"Europace"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26678","article-title":"Left atrial appendage closure: a single center experience and comparison of two contemporary devices","volume":"89","author":"Figini F","year":"2017","unstructured":"Figini F, Mazzone P, Regazzoli D, et al.. Left atrial appendage closure: a single center experience and comparison of two contemporary devices. Catheter Cardiovasc Interv. 2017, 89:763-72. 10.1002\/ccd.26678","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-1134","article-title":"Left atrial appendage occlusion in non-valvular atrial fibrillation in a Korean multi-center registry","volume":"80","author":"Kim JS","year":"2016","unstructured":"Kim JS, Lee H, Suh Y, et al.. Left atrial appendage occlusion in non-valvular atrial fibrillation in a Korean multi-center registry. Circ J. 2016, 80:1123-30. 10.1253\/circj.CJ-15-1134","journal-title":"Circ J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100893","article-title":"Comparison between Amulet and Watchman left atrial appendage closure devices: a real-world, single center experience","volume":"37","author":"Saad M","year":"2021","unstructured":"Saad M, Risha O, Sano M, et al.. Comparison between Amulet and Watchman left atrial appendage closure devices: a real-world, single center experience. Int J Cardiol Heart Vasc. 2021, 37:100893. 10.1016\/j.ijcha.2021.100893","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-19-01027","article-title":"WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry","volume":"16","author":"Ledwoch J","year":"2020","unstructured":"Ledwoch J, Franke J, Akin I, et al.. WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry. EuroIntervention. 2020, 16:e942-9. 10.4244\/EIJ-D-19-01027","journal-title":"EuroIntervention"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.10.010","article-title":"Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience","volume":"121","author":"Chiu FC","year":"2022","unstructured":"Chiu FC, Huang PS, Chen JJ, Hwang JJ, Tsai CT. Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience. J Formos Med Assoc. 2022, 121:1442-9. 10.1016\/j.jfma.2021.10.010","journal-title":"J Formos Med Assoc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-00201","article-title":"Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study","volume":"16","author":"Gloekler S","year":"2020","unstructured":"Gloekler S, F\u00fcrholz M, de Marchi S, et al.. Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study. EuroIntervention. 2020, 16:e767-774. 10.4244\/EIJ-D-20-00201","journal-title":"EuroIntervention"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure","volume":"70","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al.. 5-year outcomes after left atrial appendage closure. J Am Coll Cardiol. 2017, 70:2964-75. 10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"key":"ref40","unstructured":"CHAMPION-AF clinical trial (CHAMPION-AF). (2025). https.\/\/clinicaltrials.gov\/study\/NCT04394546."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus Warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli AP","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, et al.. Direct oral anticoagulants versus Warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022, 145:242-55. 10.1161\/CIRCULATIONAHA.121.056355","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.09.002","article-title":"Comparative safety of transcatheter LAAO with the first-generation Watchman and next-generation WATCHMAN FLX devices","volume":"15","author":"Price MJ","year":"2022","unstructured":"Price MJ, Friedman DJ, Du C, Wang Y, Lin Z, Curtis JP, Freeman JV. Comparative safety of transcatheter LAAO with the first-generation Watchman and next-generation WATCHMAN FLX devices. JACC Cardiovasc Interv. 2022, 15:2115-23. 10.1016\/j.jcin.2022.09.002","journal-title":"JACC Cardiovasc Interv"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1159\/000524626","article-title":"Comparison between Amplatzer and Watchman Left Atrial Appendage closure devices for stroke prevention in atrial fibrillation: a systematic review and meta-analysis","volume":"147","author":"Qiao J","year":"2022","unstructured":"Qiao J, Zhang B, Wang J, Pan L, Cheng T, Wang Y, Xiong E. Comparison between Amplatzer and Watchman Left Atrial Appendage closure devices for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Cardiology. 2022, 147:290-7. 10.1159\/000524626","journal-title":"Cardiology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy VY","year":"2011","unstructured":"Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011, 123:417-24. 10.1161\/CIRCULATIONAHA.110.976449","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa219","article-title":"Utilization and procedural adverse outcomes associated with Watchman device implantation","volume":"23","author":"Khalil F","year":"2021","unstructured":"Khalil F, Arora S, Killu AM, et al.. Utilization and procedural adverse outcomes associated with Watchman device implantation. Europace. 2021, 23:247-53. 10.1093\/europace\/euaa219","journal-title":"Europace"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-21-00286","article-title":"Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative study","volume":"17","author":"Piayda K","year":"2021","unstructured":"Piayda K, Sievert K, Della Rocca DG, et al.. Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative study. EuroIntervention. 2021, 17:e1033-40. 10.4244\/EIJ-D-21-00286","journal-title":"EuroIntervention"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.07.013","article-title":"Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation","volume":"266","author":"Kir D","year":"2023","unstructured":"Kir D, Van Houten HK, Walvatne KN, et al.. Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation. Am Heart J. 2023, 266:14-24. 10.1016\/j.ahj.2023.07.013","journal-title":"Am Heart J"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2024.07.010","article-title":"Impact of operator experience on left atrial appendage occlusion outcomes","volume":"10","author":"Zhang T","year":"2024","unstructured":"Zhang T, Gao C, Liu J, et al.. Impact of operator experience on left atrial appendage occlusion outcomes. JACC Clin Electrophysiol. 2024, 10:2461-70. 10.1016\/j.jacep.2024.07.010","journal-title":"JACC Clin Electrophysiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0351-y","article-title":"Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation","volume":"16","author":"Lee VW","year":"2016","unstructured":"Lee VW, Tsai RB, Chow IH, Yan BP, Kaya MG, Park JW, Lam YY. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. BMC Cardiovasc Disord. 2016, 16:167. 10.1186\/s12872-016-0351-y","journal-title":"BMC Cardiovasc Disord"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab847","article-title":"Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation","volume":"43","author":"Labori F","year":"2022","unstructured":"Labori F, Persson J, Bonander C, Jood K, Svensson M. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation. Eur Heart J. 2022, 43:1348-56. 10.1093\/eurheartj\/ehab847","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/432564-comparative-safety-and-efficacy-of-left-atrial-appendage-occlusion-technologies-for-prevention-of-stroke-and-bleeding-in-atrial-fibrillation-a-comprehensive-meta-analysis-of-watchman-versus-oral-anticoagulation-and-alternative-device-platforms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:09:35Z","timestamp":1766981375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/432564-comparative-safety-and-efficacy-of-left-atrial-appendage-occlusion-technologies-for-prevention-of-stroke-and-bleeding-in-atrial-fibrillation-a-comprehensive-meta-analysis-of-watchman-versus-oral-anticoagulation-and-alternative-device-platforms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.100284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}